Table 1.
• In vivo genome-editing products (gene therapy products that use at least one genome-editing technology and that are administered directly in the body) |
➢ Gene therapy vector products for genome editing (gene therapy products consisting of a viral or plasmid vector that expresses desired proteins, that is, nucleases used for genome editing) and gRNAs for genome editing |
➢ mRNA products for genome editing (mRNA that expresses desired proteins for genome editing) |
➢ Protein products for genome editing (desired proteins or protein/gRNA complexes used for genome editing) |
• Ex vivo genome-editing products (human cell-based products genetically modified by a genome-editing tool) |
gRNA, guide RNA; mRNA, messenger RNA.